Source link : https://www.newshealth.biz/health-news/should-car-t-best-be-used-in-early-mm-relapse/
HOUSTON — Chimeric antigen receptor T-cell therapy (CAR T) has emerged as a game changer for the treatment of multiple myeloma (MM), but questions remain as to how — and when — the immunotherapy will best be used for patients who experience disease relapse. Will CAR T be best used in early relapse? Experts debated […]
Author : News Health
Publish date : 2024-09-12 09:11:38
Copyright for syndicated content belongs to the linked Source.
Categories